Výsledky hledání
  1. 27. 8.

    | Gland Pharma increases contract manufacturing of , will now manufacture the drug for four companies, sources tell

  2. 25. 8.

    🧵5/9 Key unknowns Very few data on exposure in 1st trimester when organogenesis occurs No adverse findings in pre-clinical reproductive & developmental studies

    Zobrazit toto vlákno
  3. před 24 hodinami

    One more reason why we need an oral version of , like ...

  4. 27. 8.

    | Sources say that Gland Pharma has increased contract manufacturing of . gets us the details.

  5. 25. 8.

    🧵4/9 was made available to 🤰🏽 patients through Gilead's compassionate use program while RCTs ongoing, but less comprehensive safety monitoring, limited follow-up & sparse data collection with these programs vs. RCT 🤨

    Zobrazit toto vlákno
  6. 24. 8.

    Group arrested for impersonating veteran politician also scored scarce remdesivir during the second wave and sold them in the black market at high prices.

  7. 25. 8.

    🧵6/9 Placental transfer? Don't know, but hydrolyzed quickly so unlikely Active metabolites may have higher passage (some have long half-lives, low molecular weight, high free fraction, favoring passage)

    Zobrazit toto vlákno
  8. 29. 8.

    Is still the go-to drug in PH? I really hope it’s not overpriced and are available to those who need it 😔

  9. 24. 8.

    India is creating buffer stocks of critical meds for , to prepare for the impending third wave. Stocks of 15-odd incl , & AmphotericinB will be maintained. This may prevent massive shortages & black marketing: my story

  10. 24. 8.

    Our colleague Sara Vidlin is presenting UMC's analysis of reports on the treatment at (23-25 Aug). View the poster in full and listen to her audio presentation here:

  11. 24. 8.
    Odpověď uživatelům

    Tagging our awesome coauthor for the 🤰🤱review 🙂

  12. 27. 8.

    sales will depend on the third wave of , says Nithya Balasubramanian, Director at Sanford Bernstein. She tells , & that the drug size is likely to shrink.

  13. 23. 8.

    Is there a clinical benefit to early or co-initiation of relative to compared to delayed introduction or non-users? Read Wong, et al’s findings here:

    https://doi.org/10.1093/cid/ciab728
  14. 27. 8.

    In the first phase of , antivirals like and monoclonal antibodies target the virus well. Treating the second phase, during which the immune response itself is the cause of whole-body organ damage, involves dampening the immune system.

  15. 25. 8.
    Zobrazit toto vlákno
  16. 25. 8.

    New : What are the effects of for the treatment of ? Based on the systematic review

  17. is the only Food and Drug Administration-approved drug for the treatment of . Find our recommendations on using remdesivir with or without here:

  18. 30. 8.

    Regeneron (REGN). Short term consolidation after breakout of large consolidation pattern. This is a new, fresh bull market.

  19. 24. 8.

    Happy to be participating in ! Visit our posters: 1⃣ Safety Monitoring During the Pandemic: 2⃣ & Nightmare – Further Characterisation Using Data from :

  20. 25. 8.

    For those want an example of how “expertise” is trumped by due diligence, consider how a debutant developed a better grasp of the PK/PD/tox of versus its simpler precursor, , than the “experts” .

Načítání se zjevně nějak vleče.

Možná je překročena kapacita Twitteru nebo došlo k momentálnímu zablokování. Zkuste to znovu nebo se podívejte na stavovou stránku Twitteru, kde najdete další informace.